MEDICAL ALLIANCE OFFERS NEXT-GENERATION FIBER OPTIC TECHNOLOGY.
The Versascope diagnostic and operative hysteroscopy system enables obstetricians and gynecologists to see abnormal uterine growths including endometriosis, polyps, fibroids and pre-cancerous lesions with a wider field of view within the uterine cavity. This system is small enough to be inserted through most cervices without dilation or anesthesia required - the hysteroscope and sheath are designed to minimize patient trauma and discomfort. Advanced optics technology ensures precise imaging for accurate diagnostic and therapeutic procedures. The unique expandable channel of the Versascope Sheath allows delivery of 2mm instruments including the biopsy cup, grasper and scissors.
"Medical Alliance has been offering diagnostic and operative hysteroscopy services to obstetricians and gynecologists for some time now, and we are pleased to offer this most recent technological advancement to them," said Paul Herchman, chief executive officer of Medical Alliance, Inc. "This new fiber optic technology will enable physicians to see a wider view of the intrauterine cavity enabling them to diagnose a number of abnormalities. We are pleased to offer another Gynecare/Ethicon, Johnson & Johnson Company product to our physician customers."
Medical Alliance provides technology and a complete range of surgical services in hospitals, surgery centers, and physicians' offices in 42 states. At present, Medical Alliance has 168 managed care contracts covering approximately 82 million lives. The Company provides its services along two primary business lines - medical surgical and aesthetic elective services. Payors, physicians and patients benefit from Medical Alliance's services through reduced costs for surgical procedures, increased physician productivity, greater access to advanced medical technologies and improved patient satisfaction.
For more information, visit www.medalliance.com or call 972/580-8999.
|Printer friendly Cite/link Email Feedback|
|Publication:||Biotech Equipment Update|
|Date:||Mar 1, 2000|
|Previous Article:||MILESTONE ANNOUNCES CHANGE IN DISTRIBUTION FOR "THE WAND".|
|Next Article:||CTI SUBMITS SECOND MODULE TO FDA FOR CANCER DETECTION SYSTEM.|